Past, Present and Future of Therapeutic Interventions Targeting Leukocyte Trafficking in Inflammatory Bowel Disease. [electronic resource]
Producer: 20190111Description: S633-S640 p. digitalISSN:- 1876-4479
- Animals
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Cell Adhesion Molecules
- Cell Communication -- drug effects
- Chemotaxis, Leukocyte -- drug effects
- Endothelial Cells -- physiology
- Fingolimod Hydrochloride -- therapeutic use
- Gastrointestinal Agents -- pharmacology
- Gastrointestinal Tract -- immunology
- Humans
- Immunoglobulins
- Immunosuppressive Agents -- therapeutic use
- Indans -- therapeutic use
- Inflammatory Bowel Diseases -- drug therapy
- Integrins -- antagonists & inhibitors
- Intercellular Adhesion Molecule-1
- Leukocytes -- physiology
- Lysophospholipids -- agonists
- Mucoproteins -- antagonists & inhibitors
- Natalizumab -- therapeutic use
- Oxadiazoles -- therapeutic use
- Phosphorothioate Oligonucleotides -- therapeutic use
- Receptors, Lysosphingolipid -- agonists
- Sphingosine -- agonists
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.